Washington, D.C-based private equity firm with over $7 billion of assets under management and extensive experience investing in industries that serve or are regulated by the government.

Key Investment Statistics

140+

Total Transactions

21

Active Portfolio Companies

$3B+

Total Capital Invested

$7B

Total AUM

  • Latest News
  • Aerospace & Defense
  • Government Services & Technology
  • Healthcare
  • Business Services & Software
November 29, 2023
BlueHalo, an Arlington Capital Partners Portfolio Company, Acquires Leading SDR Provider Ipsolon Research, Strengthening Next-Generation Defense Technology Platform
November 20, 2023
Arlington Capital Partners Completes Acquisition of Exostar
November 07, 2023
Qarbon Aerospace, an Arlington Capital Partners Portfolio Company, Appoints Michael Canario as CEO
November 07, 2023
Everest Clinical Research, an Arlington Capital Partners Portfolio Company, Acquires August Research
November 01, 2023
Arlington Capital Partners-Backed Eqlipse Technologies to Acquire SR Technologies
November 07, 2023
Qarbon Aerospace, an Arlington Capital Partners Portfolio Company, Appoints Michael Canario as CEO
October 12, 2023
Arlington Capital Partners-Backed Stellant Systems to Acquire Power Systems Technology Product Line from Comtech
September 13, 2023
Arlington Capital Partners-Backed Pegasus Steel Announces Key Executive and Board Appointments
June 14, 2023
Arlington Capital Partners Announces the Acquisition of Pegasus Steel
February 17, 2023
Tex Tech Industries, an Arlington Capital Partners Portfolio Company, Announces the Acquisition of SGL Carbon’s Business Activities at the Gardena, California site
November 29, 2023
BlueHalo, an Arlington Capital Partners Portfolio Company, Acquires Leading SDR Provider Ipsolon Research, Strengthening Next-Generation Defense Technology Platform
November 20, 2023
Arlington Capital Partners Completes Acquisition of Exostar
November 01, 2023
Arlington Capital Partners-Backed Eqlipse Technologies to Acquire SR Technologies
October 02, 2023
Arlington Capital Partners Announces the Acquisition of Avenu Insights & Analytics
September 26, 2023
Arlington Capital Partners to Acquire Exostar from Thoma Bravo
November 07, 2023
Everest Clinical Research, an Arlington Capital Partners Portfolio Company, Acquires August Research
July 18, 2023
AVS Bio Appoints Jac Price as Chief Executive Officer to Expand Bioprocessing Platform
January 05, 2023
Arlington Capital Partners Announces the Acquisition of AVS Bio
December 06, 2022
Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires Ethide Laboratories
December 01, 2022
Everest Clinical Research, an Arlington Capital Partners Portfolio Company, Announces the Acquisition of Brightech International
November 18, 2019
Arlington Capital Partners Agrees to Sell Quantum Spatial to NV5 Global, Inc. for $303 Million
June 26, 2018
Arlington Capital Partners Has Sold Zemax, Global Leader in Optical and Illumination Design Software, to EQT
August 04, 2016
Arlington Capital Partners Closes Oversubscribed Fourth Fund at its Hard Cap of $700 Million
October 24, 2014
Arlington Capital Partners Announces the Acquisition of Zemax
August 11, 2014
Arlington Capital Partners Announces the Sale of Virgo Holdings to Informa, PLC